Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Australia | Publication | October 2023
On 12 October 2023, the Government introduced the Information Privacy and Other Legislation Amendment Bill 2023 (Bill) to Queensland Parliament which, amongst other things, establishes a mandatory data breach notification scheme (MDBN Scheme) in Queensland. The Bill is consistent with the recommendations in the Coaldrake Review and is currently under consideration by the Education, Employment and Training Committee.
It is unclear when the Bill will pass, however, if enacted, the MDBN Scheme will apply to all Queensland state and local government agencies that are subject to the Information Privacy Act 2009 (Qld) (Privacy Act). Notably, the Queensland government will take a phased approach to implement the MDBN Scheme and local councils will be subject to a 12-month transition period to mitigate the resourcing impacts and costs involved to comply with the scheme.
Non-compliance with the MDBN Scheme may result in a privacy complaint being made to the Minister, compliance action under the Privacy Act or an order by the Queensland Civil and Administrative Tribunal for compensatory payments to the individual affected.
If you have any queries in respect to the potential effect of the MDBN Scheme, please feel free to contact:
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023